Why Mounjaro works so well: the dual-hormone mechanism behind the results

Step 1: two receptors fire where single-agonist medicines only reach one

After each weekly injection, tirzepatide binds to GIP receptors and GLP-1 receptors in parallel. GLP-1 (glucagon-like peptide-1) is the pathway shared with medicines like semaglutide: it signals fullness to the brain, slows gastric emptying and moderates post-meal blood sugar. GIP (glucose-dependent insulinotropic polypeptide) adds a second layer. It amplifies the insulin response to food, acts on fat tissue directly and, according to the emerging evidence, may reinforce the brain's satiety signals through a slightly different route. The two pathways don't simply add up, the combination appears to be genuinely complementary, which is a large part of why the clinical trial results for tirzepatide surprised even the researchers running them. If you'd like to understand how Mounjaro works at the receptor level, our dedicated page walks through the precise biology in detail. You can also read more about the mechanism on our tirzepatide mechanism page.

For most people the practical effect is straightforward: food stops feeling as urgent. Portions that previously felt inadequate feel sufficient. That shift isn't willpower, it's pharmacology changing the signal.

Step 2: slowed gastric emptying keeps you fuller for longer

Both GIP and GLP-1 activation delay how quickly the stomach passes food into the small intestine. Food sits in the stomach longer, which prolongs the physical sensation of fullness and blunts the sharp glucose peaks that follow a meal. Those peaks matter because they drive insulin spikes, and insulin spikes are part of the cycle that leads to energy dips and renewed hunger an hour or two after eating.

A question our prescribers hear most weeks is whether this means eating becomes uncomfortable. For most patients, especially during the early weeks, the answer is that meals simply feel satisfying at a smaller volume rather than unpleasant, though nausea, particularly after starting or moving to a higher dose, is a common experience that tends to settle within a fortnight. The timeline of when Mounjaro starts working covers what to expect in those first weeks in more detail.

Step 3: the appetite signal reaches the brain through two channels

Weight regulation is largely a brain function. The hypothalamus reads hormonal signals from the gut and adjusts hunger and energy expenditure accordingly. Tirzepatide delivers input through both the GLP-1 and GIP receptor pathways, which means a stronger and more sustained satiety signal than a single-agonist medicine can produce. In practice, people often describe thinking about food less, not being repulsed by it, just less preoccupied with it.

This is also why the SURMOUNT-5 open-label trial, published in the New England Journal of Medicine in 2025, found tirzepatide produced greater average weight reduction than semaglutide 2.4mg over 72 weeks in adults with obesity. The head-to-head comparison is the clearest evidence that the additional receptor pathway makes a meaningful difference at a population level, even if individual responses vary. NICE's appraisal of tirzepatide (TA1026) drew on this and other evidence when recommending tirzepatide for eligible adults.

Step 4: the dose schedule is designed to let your body adjust

Treatment starts at 2.5mg. That first dose is there to let the body adapt to the mechanism, gastrointestinal side effects are more likely when the full effect hits a system that hasn't encountered it before. Titration continues under prescriber oversight, typically in four-week steps through 5mg, 7.5mg, 10mg, 12.5mg and up to 15mg. The biological effect grows with each increase, which is why weight loss often accelerates once a person reaches their maintenance dose rather than peaking at the beginning.

None of that titration is something to self-direct. The prescriber's role is to judge the pace, flag any concerns and review whether the benefit justifies continuing. If you're curious about when the effects become noticeable, our page on how quickly Mounjaro works sets realistic expectations. And if you're wondering why results can plateau or feel slower than the trial figures suggest, the reasons are usually explainable, and our page on why Mounjaro doesn't work for some people goes through the most common ones. For a broader view of how Mounjaro fits alongside other weight-loss treatment options, that page covers the landscape. The NHS medicines page for tirzepatide also provides a reliable patient-level overview of how it works and what to watch for. Treatment is prescription-only and requires clinical assessment, if you'd like to explore whether it's suitable for you, the right starting point is a consultation with a prescriber.

Check your eligibility by starting a free consultation with our prescribers, reviewed the same day by a real clinician, not software.